Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

PalGlyN-palmitoylglycine

An endogenous lipoamino acid of skin and spinal cord, the most potent activator of the GPR132 receptor.

Level of detail

C₁₈H₃₅NO₃

CAS 2441-41-0

Family
Endocannabinoid or related mediatorEndocannabinoidome
Molar mass
313.50 g/mol

Updated on

In plain terms

N-palmitoylglycine is a lipid the body makes itself, by attaching a fatty acid to an amino acid. It is found mainly in skin and spinal cord, where it acts on the activity of sensory neurons.

Receptors and activity

Target network

  • Activates
  • Blocks or inhibits

The lower the cited value, the closer the target sits to PalGly: one ring per factor of 100. A target with no measured value stays on the edge.

Cited values

  1. GPR132 (G2A)Agonistno measured value cited

    Most potent activator among the N-acylamides tested: N-palmitoylglycine > 9-HODE ≈ N-linoleoylglycine > linoleamide > N-oleoylglycine ≈ N-stearoylglycine > N-arachidonoylglycine > N-docosahexaenoylglycine, with activity comparable to that of 9-HODE; physiological tissue concentrations are enough to activate the receptor, and arginine 203 of the fifth transmembrane domain is critical (Foster 2019). No EC50 is given in the abstract

  2. Dorsal horn nociceptive neurons (heat-evoked firing)Inhibitorno measured value cited

    Potent inhibition of heat-evoked firing in the rat; transient calcium influx in dorsal root ganglion neurons and in the F-11 line, sensitive to pertussis toxin, dependent on extracellular calcium, blocked by ruthenium red, SK&F96365 and lanthanum, followed by NO production suppressed by 7-nitroindazole (Rimmerman 2008). No potency value published in the abstract

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Pharmacology

N-palmitoylglycine is an endogenous lipoamino acid, the saturated congener of N-arachidonoylglycine in the N-acylglycine family. Rimmerman and colleagues identified it in 2008 in rat lipid extracts after postulating its existence from the availability of its two building blocks, palmitic acid and glycine, and found it at high levels in skin and spinal cord, raised in FAAH-deficient mice. In the same work it inhibited heat-evoked firing of nociceptive dorsal horn neurons and triggered a transient calcium influx in sensory neurons, sensitive to pertussis toxin and followed by nitric oxide production, which places it in sensory signalling rather than in cannabinoid neurotransmission. Its best-characterised molecular target is the lipid receptor GPR132 (G2A): it is the most potent activator among the N-acylamides tested, ahead of 9-HODE and N-linoleoylglycine, at concentrations tissues actually reach (Foster 2019). It does not directly activate the CB1 and CB2 receptors. Its interest therefore lies in the lipid entourage of the endocannabinoid system: for this class, inhibition of T-type calcium channels has been proposed as the mechanism of the analgesia observed, N-arachidonoylglycine and NAGABA-OH producing a thermal analgesia abolished in mice lacking Cav3.2, though N-palmitoylglycine itself was not tested in that work (Barbara 2009).

History

Source
An endogenous mammalian lipid, formed after cellular stimulation and present at high levels in rat skin and spinal cord (Rimmerman 2008). It belongs to the lipoamino acid family, the saturated congener of N-arachidonoylglycine, and comes from no plant source.

Biosynthetic pathway

In vivo

Conjugation of palmitic acid, a saturated sixteen-carbon fatty acid, with glycine. For the family's lead compound, N-arachidonoylglycine, two routes are described: direct conjugation of the fatty acid to glycine and oxidative metabolism of anandamide; it was the existence of enzymes conjugating fatty acids with glycine that prompted the hypothesis of endogenous N-palmitoylglycine formation (Rimmerman 2008). Its elevation in FAAH-deficient mice indicates that its tissue level is under enzymatic control. This route is distinct from that of N-acylethanolamines such as anandamide, where ethanolamine rather than an amino acid carries the amide function.

Classification

Family, origin and source verification

Family

Endocannabinoid or related mediator › Endocannabinoidome

Verification

Every fact on this entry was checked against its primary sources on 20 October 2026.

Wikipedia (English)

No dedicated article.

References

Identifiers

Names

Common name
N-palmitoylglycine
IUPAC name
2-(hexadecanoylamino)acetic acid
Other names
PalGly · N-palmitoyl glycine · palmitoylglycine

Identifiers

Formula
C₁₈H₃₅NO₃
CAS
2441-41-0
PubChem CID
151008(new tab)
InChIKey
KVTFEOAKFFQCCX-UHFFFAOYSA-N
SMILES
CCCCCCCCCCCCCCCC(=O)NCC(=O)O

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.